口蹄疫疫苗市场：依疫苗类型、依动物类型、依地区

预计2024年全球口蹄疫疫苗市场规模为29亿美元，预计2031年将达51.2亿美元，2024年至2031年复合年增长率为8.5%。

图 1. 2024 年按地区分類的口蹄疫疫苗市场占有率(%)

口蹄疫 (FMD) 是一种高度传染性的病毒性疾病，影响牛、猪、绵羊、山羊和鹿等有蹄牲畜。这种疾病可造成严重损害，包括直接影响产乳量和受感染牲畜的生长，以及透过预防、治疗和贸易限製造成间接经济损失。口蹄疫在亚洲、非洲和南美洲部分地区流行，目前正在实施紧急疫苗接种以遏制疫情爆发。随着国际贸易和牲畜流动的增加，管理口蹄疫变得越来越困难，需要改善疫苗策略和干预措施。

市场动态：

全球口蹄疫疫苗市场的成长是由以下因素推动的：牲畜口蹄疫盛行率不断上升、气候和耕作方式变化导致的全球疫情日益严重以及动物和牲畜的国际贸易产品。然而，与疫苗生产、储存和设备再利用相关的高成本可能会阻碍市场成长。此外，各国疫苗核准缺乏标准化监管指引也阻碍了市场成长。新兴的分子生物学技术能够开发具有改善的免疫抗原性和交叉保护的新一代疫苗，可能会提供市场成长的机会。在以前缺乏口蹄疫控制的国家中，对口蹄疫控制的日益重视可能会开拓新的应用领域。

本研究的主要特点

• 本报告对全球口蹄疫疫苗市场进行了详细分析，并列出了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为预测期。做。
• 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球口蹄疫疫苗市场的主要企业。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球口蹄疫疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于分析全球口蹄疫疫苗市场的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球口蹄疫疫苗市场－冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章2019-2031年全球口蹄疫疫苗市场（依疫苗类型）

• 常规疫苗
• 氢氧化铝疫苗
• 油性疫苗
• 紧急疫苗

第六章 全球口蹄疫疫苗市场（依动物类型），2019-2031

• 牛
• 绵羊和山羊
• 猪
• 其他的

第七章2019-2031年全球口蹄疫疫苗市场（按地区）

• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck &Co., Inc.（MSD Animal Health）
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica SA
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI-Federal Centre for Animal Health
  • Vecol SA
  • Laboratorios Agrovet SA
  • Centro Diagnostico Veterinario
  • Razi Vaccine &Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

第九章 分析师建议

• 命运之轮
• 分析师观点
• 一致的机会图

第10章 参考文献与调查方法

• 参考
• 调查方法

Global foot and mouth disease vaccine market is estimated to be valued at USD 2.90 Bn in 2024 and is expected to reach USD 5.12 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5 % from 2024 to 2031.

Figure 1. Foot and Mouth Disease Vaccine Market Share (%), By Region, 2024

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals including cattle, pigs, sheep, goats, deer and other livestock. The disease can cause severe damage both direct loss in milk yield and growth in infected animals and indirect economic losses from control, treatment and trade restrictions. FMD is a endemic in parts of Asia, Africa, and South America where emergency vaccination is practiced to control outbreaks. With growing international trade and movement of livestock, controlling FMD has become more challenging, thus, requiring improved vaccination strategies and interventions.

Market Dynamics:

Global foot and mouth disease vaccine market growth is driven by factors such as increasing prevalence of FMD amongst livestock, growing outbreaks worldwide due to changes in climate and farming practices as well as international trade in animals and animal products. However, high costs associated with vaccine production and storage and reuse of equipment can hamper the market growth. Furthermore, lack of standardized regulatory guidelines for vaccine approval in different countries also hampers the market growth. Advancements in molecular biological techniques that enables development of new generation vaccines with improved immunogenicity and cross-protection can offer market growth opportunity. Growing focus on controlling FMD in previously FMD-free countries can open new application areas.

Key Features of the Study:

• This report provides in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Merck & Co., Biogenesis Bago, Indian Immunologicals Ltd., Boehringer Ingelheim, Vetal Animal Health
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation

• By Vaccine Type:
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• By Animal Type
  • Cattle
  • Sheep and Goat
  • Swine
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc. (MSD Animal Health)
  • Indian Immunologicals Ltd.
  • Limber Laboratories Pvt. Ltd.
  • Brilliant Bio Pharma Private Limited
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Foot and Mouth Disease Vaccine Market, By Vaccine Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Conventional Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Aluminum Hydroxide based vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Oil based Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Emergency Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Foot and Mouth Disease Vaccine Market, By Animal Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cattle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Sheep and Goat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Swine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Foot and Mouth Disease Vaccine Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Merck & Co., Inc. (MSD Animal Health)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Indian Immunologicals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Limber Laboratories Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Brilliant Bio Pharma Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Inova Biotechnologia Saude Animal Ltda.
  • Biovet Vaxxinova
  • Veterquimica S.A.
  • MEVAC
  • Agrovet
  • Biogenesis Bago
  • FGBI - Federal Centre for Animal Health
  • Vecol S.A.
  • Laboratorios Agrovet S.A.
  • Centro Diagnostico Veterinario
  • Razi Vaccine & Serum Research Institute
  • VETAL Animal Health Veterinary Pharmaceuticals

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact